海外の治験の状況「1」での検索結果
1852件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
- Childhood Renal Cell Carcinoma;Clear Cell Renal Cell Carcinoma;Clear Cell Sarcoma of the Kidney;Papillary Renal Cell Carcinoma;Rhabdoid Tumor of the Kidney;Stage I Renal Cell Cancer;Stage I Renal Wilms Tumor;Stage II Renal Cell Cancer;Stage II Renal Wilms Tumor;Stage III Renal Cell Cancer;Stage III Renal Wilms Tumor;Stage IV Renal Cell Cancer;Stage IV Renal Wilms Tumor;Childhood Renal Cell Carcinoma;Clear Cell Renal Cell Carcinoma;Clear Cell Sarcoma of the Kidney;Papillary Renal Cell Carcinoma;Rhabdoid Tumor of the Kidney;Stage I Renal Cell Cancer;Stage I Renal Wilms Tumor;Stage II Renal Cell Cancer;Stage II Renal Wilms Tumor;Stage III Renal Cell Cancer;Stage III Renal Wilms Tumor;Stage IV Renal Cell Cancer;Stage IV Renal Wilms Tumor;Childhood Renal Cell Carcinoma;Clear Cell Renal Cell Carcinoma;Clear Cell Sarcoma of the Kidney;Papillary Renal Cell Carcinoma;Rhabdoid Tumor of the Kidney;Stage I Renal Cell Cancer;Stage I Renal Wilms Tumor;Stage II Renal Cell Cancer;Stage II Renal Wilms Tumor;Stage III Renal Cell Cancer;Stage III Renal Wilms Tumor;Stage IV Renal Cell Cancer;Stage IV Renal Wilms Tumor;Childhood Renal Cell Carcinoma;Clear Cell Renal Cell Carcinoma;Clear Cell Sarcoma of the Kidney;Papillary Renal Cell Carcinoma;Rhabdoid Tumor of the Kidney;Stage I Renal Cell Cancer;Stage I Renal Wilms Tumor;Stage II Renal Cell Cancer;Stage II Renal Wilms Tumor;Stage III Renal Cell Cancer;Stage III Renal Wilms Tumor;Stage IV Renal Cell Cancer;Stage IV Renal Wilms Tumor
- Australia, Canada, New Zealand, Puerto Rico, United States
- 2006-06-08
Not recruiting
- Epilepsy Phenome/Genome Project
- Epilepsy;Localization-related Epilepsy;Infantile Spasms;Lennox-Gastaut Syndrome;Polymicrogyria;Periventricular Heterotopias
- Argentina, Australia, United States
- 2007-10-30
Not recruiting
- Early Access Program (EAP) of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or With FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)
- Acute Myeloid Leukemia (AML);FMS-like Tyrosine Kinase-3 (FLT3) Mutations
- Australia, Italy, United Kingdom
- 2018-01-18
Not Recruiting
- The effect of low energy availability and low carbohydrate availability on hormone status, metabolism and performance in elite race walkers ('Supernova 4")
- High-performance athlete nutrition;Reproductive hormones (testosterone, LH);Bone metabolism;Metabolic hormones (T3, IGF1. leptin, cortisol); br>High-performance athlete nutrition Reproductive hormones (testosterone, LH) Bone metabolism Metabolic hormones (T3, IGF1. leptin, cortisol);Diet and Nutrition - Other diet and nutrition disorders;Metabolic and Endocrine - Normal metabolism and endocrine development and function;Musculoskeletal - Normal musculoskeletal and cartilage development and function
- Australia, Canada, Chile, Colombia, Japan, Lithuania, Mexico, New Zealand, Poland, Slovakia, South Africa, Sweden
- 2018-12-07
Not Recruiting
- Catheter Ablation versus Medical Therapy for Ventricular Tachycardia in Non-Ischemic Heart Disease: A Randomised Trial
- Non-Ischemic Cardiomyopathy;Ventricular Tachycardia;Dilated Cardiomyopathy;Sarcoidosis;Hypertrophic Cardiomyopathy;Arrhythmogenic right ventricular cardiomyopathy; Non-Ischemic Cardiomyopathy Ventricular Tachycardia Dilated Cardiomyopathy Sarcoidosis Hypertrophic Cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy;Cardiovascular - Other cardiovascular diseases
- Australia
- 2020-01-21
Not recruiting
- The effect of Amlamax (made from Indian gooseberry) on raising good cholesterol.
- 'Subjective Memory function';Cardiovascular risk factors with metabolic syndrome such as hypertension, Obesity, dyslipidemia;Alzheimer's Disease.;Low high density lipoprotein cholesterol (HDL-C).
- Australia
- 2011-04-27
Not Recruiting
- A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic EMICIZUMAB versus No Prophylaxis in Hemophilia A Patients with Inhibitors
- Hemophilia A with Inhibitors MedDRA version: 19.1 Level: LLT Classification code 10060612 Term: Hemophilia A System Organ Class: 100000004850 MedDRA version: 19.1 Level: LLT Classification code 10053751 Term: Hemophilia A with anti factor VIII System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Australia, Costa Rica, France, Germany, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Taiwan, United Kingdom, United States
- 2015-09-04
Not recruiting
- Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
- Breast Tumor;Breast Cancer;Cancer of the Breast;Estrogen Receptor- Negative Breast Cancer;HER2- Negative Breast Cancer;Progesterone Receptor- Negative Breast Cancer;Recurrent Breast Cancer;Stage IV Breast Cancer;Triple-negative Breast Cancer;Triple-negative Metastatic Breast Cancer;Metastatic Breast Cancer
- Australia, Austria, Brazil, Canada, France, Germany, Greece, Italy, Portugal, Spain, United Kingdom, United States
- 2013-06-17
Not Recruiting
- A Study Comparing MK-8808 to MabThera™ in Patients with Advanced Follicular Lymphoma.
- Previously untreated patients with CD20-positive follicular lymphoma, Grade 1, 2 or 3a according to the WHO 2008 classification system. MedDRA version: 14.1 Level: LLT Classification code 10059432 Term: Follicular mixed small and large cell lymphoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Belarus, Brazil, Canada, Chile, China, Croatia, Egypt, Georgia, India, Israel, Italy, Korea, Republic of, Malaysia, Mexico, New Zealand, Peru, Philippines, Russian Federation, Singapore, South Africa, Taiwan, Thailand, Ukraine
- 2013-01-11
Not Recruiting
- A Phase 2/ 3 trial to evaluate the efficacy and safety of BAY86-6150
- Subjects with hemophilia A or B with inhibitors MedDRA version: 14.1 Level: LLT Classification code 10053751 Term: Hemophilia A with anti factor VIII System Organ Class: 100000004850 MedDRA version: 14.1 Level: LLT Classification code 10053752 Term: Hemophilia B with anti factor IX System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Argentina, Australia, Brazil, Bulgaria, Chile, China, Colombia, Denmark, European Union, France, Germany, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2012-05-11
Not Recruiting
- A study to assess patient preference after subcutaneous injections of Mabthera versus intravenous infusions Mabthera in previously-untreated patients with diffuse large B-cell lymphoma or follicular non-Hodgkin’s lymphoma.
- The target population will consist of adults with previously untreated CD20+ DLBCL or CD20+ follicular NHL Grade 1, 2 or 3a, according to the WHO classification system. MedDRA version: 18.0 Level: PT Classification code 10012818 Term: Diffuse large B-cell lymphoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Croatia, Denmark, Dominican Republic, Egypt, El Salvador, France, Germany, Guatemala, Hong Kong, Hungary, Indonesia, Ireland, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Panama, Peru, Philippines, Portugal, Romania, Sweden, Switzerland, Taiwan, Thailand, Turkey, Vietnam
- 2012-10-08
Not Recruiting
- Study of recombinant factor VIIa fusion protein (rVIIa-FP, CSL689) for on-demand treatment of bleeding episodes in patients with hemophilia A or B with inhibitors.
- Hemophilia A with inhibitors, Hemophilia B with inhibitors MedDRA version: 20.0 Level: LLT Classification code 10053751 Term: Hemophilia A with anti factor VIII System Organ Class: 100000004850 MedDRA version: 20.0 Level: LLT Classification code 10053752 Term: Hemophilia B with anti factor IX System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Australia, Canada, European Union, Georgia, Germany, Japan, Korea, Republic of, Malaysia, Russian Federation, Serbia, South Africa, Spain, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2013-10-02
Not recruiting
- The effect of broccoli consumption on the activity of drug metabolising enzymes in people of European and South Asian ancestry
- Altered drug-metabolising enzyme activity (CYP1A2, CYP2C19, CYP2C9, CYP2D6 and CYP3A4) in people of European and South Asian ancestry.
- Australia
- 2013-10-03
Not Recruiting
- A study of fitusiran (ALN-AT3SC) in hemophilia A and B patients previously receiving factor or bypassing agent prophylaxis
- Hemophilia A or Hemophilia B MedDRA version: 20.0 Level: LLT Classification code 10060613 Term: Hemophilia A (Factor VIII) System Organ Class: 100000011915 MedDRA version: 20.0 Level: LLT Classification code 10060614 Term: Hemophilia B (Factor IX) System Organ Class: 100000011913 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Australia, Brazil, Bulgaria, Canada, China, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Portugal, Russian Federation, South Africa, Spain, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2017-07-12
Not Recruiting
- A study of fitusiran (ALN-AT3SC) in hemophilia A and B patients without inhibitors
- Hemophilia A or Hemophilia B MedDRA version: 20.0 Level: LLT Classification code 10060613 Term: Hemophilia A (Factor VIII) System Organ Class: 100000011915 MedDRA version: 20.0 Level: LLT Classification code 10060614 Term: Hemophilia B (Factor IX) System Organ Class: 100000011913 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Australia, Brazil, Bulgaria, Canada, China, Denmark, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2017-07-05
Not recruiting
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
- Adult Rhabdomyosarcoma;Adult Synovial Sarcoma;Childhood Hepatoblastoma;Childhood Synovial Sarcoma;Previously Treated Childhood Rhabdomyosarcoma;Recurrent Adrenocortical Carcinoma;Recurrent Adult Soft Tissue Sarcoma;Recurrent Childhood Liver Cancer;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Soft Tissue Sarcoma;Recurrent Ewing Sarcoma/Peripheral Primitive;Neuroectodermal Tumor;Recurrent Neuroblastoma;Recurrent Osteosarcoma;Recurrent Retinoblastoma;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Adult Rhabdomyosarcoma;Adult Synovial Sarcoma;Childhood Hepatoblastoma;Childhood Synovial Sarcoma;Previously Treated Childhood Rhabdomyosarcoma;Recurrent Adrenocortical Carcinoma;Recurrent Adult Soft Tissue Sarcoma;Recurrent Childhood Liver Cancer;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Soft Tissue Sarcoma;Recurrent Ewing Sarcoma/Peripheral Primitive;Neuroectodermal Tumor;Recurrent Neuroblastoma;Recurrent Osteosarcoma;Recurrent Retinoblastoma;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Adult Rhabdomyosarcoma;Adult Synovial Sarcoma;Childhood Hepatoblastoma;Childhood Synovial Sarcoma;Previously Treated Childhood Rhabdomyosarcoma;Recurrent Adrenocortical Carcinoma;Recurrent Adult Soft Tissue Sarcoma;Recurrent Childhood Liver Cancer;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Soft Tissue Sarcoma;Recurrent Ewing Sarcoma/Peripheral Primitive;Neuroectodermal Tumor;Recurrent Neuroblastoma;Recurrent Osteosarcoma;Recurrent Retinoblastoma;Recurrent Wilms Tumor and Other Childhood Kidney Tumors;Adult Rhabdomyosarcoma;Adult Synovial Sarcoma;Childhood Hepatoblastoma;Childhood Synovial Sarcoma;Previously Treated Childhood Rhabdomyosarcoma;Recurrent Adrenocortical Carcinoma;Recurrent Adult Soft Tissue Sarcoma;Recurrent Childhood Liver Cancer;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Soft Tissue Sarcoma;Recurrent Ewing Sarcoma/Peripheral Primitive;Neuroectodermal Tumor;Recurrent Neuroblastoma;Recurrent Osteosarcoma;Recurrent Retinoblastoma;Recurrent Wilms Tumor and Other Childhood Kidney Tumors
- Australia, Canada, United States
- 2009-01-28
Not Recruiting
- Efficacy and Safety of NNC 0078-0000-0007 in Treatment of Acute Bleeding Episodes in Patients born with Haemophilia and having Inhibitors
- Congenital Haemophilia and Inhibitors MedDRA version: 13.1 Level: PT Classification code 10056492 Term: Haemophilia A with anti factor VIII System Organ Class: 10010331 - Congenital, familial and genetic disorders MedDRA version: 13.1 Level: PT Classification code 10056494 Term: Haemophilia B with anti factor IX System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Austria, Brazil, Croatia, Denmark, France, Greece, Hungary, India, Italy, Japan, Malaysia, Poland, Romania, Russian Federation, Serbia, South Africa, Spain, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2011-05-19
Not recruiting
- APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors
- Solid Tumor;Advanced Cancers;Colorectal Cancer;Gastric Cancer;Hepatocellular Cancer;Non Small Cell Lung Cancer;Renal Cancer;Head and Neck Squamous Cell Carcinoma;CHL;Urothelial Carcinoma;Gastroesophageal Junction Adenocarcinoma;Microsatellite Instability;Mismatch Repair Deficiency;Esophageal Cancer;Cancer of Unknown Primary Site;Carcinosarcoma
- Australia
- 2017-01-30
Not recruiting
- Ixabepilone in Treating Young Patients With Refractory Solid Tumors
- Adult Rhabdomyosarcoma;Adult Synovial Sarcoma;Alveolar Childhood Rhabdomyosarcoma;Childhood Synovial Sarcoma;Embryonal Childhood Rhabdomyosarcoma;Previously Treated Childhood Rhabdomyosarcoma;Recurrent Adult Soft Tissue Sarcoma;Recurrent Childhood Rhabdomyosarcoma;Recurrent Childhood Soft Tissue Sarcoma;Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;Recurrent Neuroblastoma;Recurrent Osteosarcoma;Recurrent Wilms Tumor and Other Childhood Kidney Tumors
- Australia, Canada, New Zealand, United States
- 2006-05-30
Not recruiting
- The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
- Diabetes Mellitus, Non-Insulin-Dependent;Diabetes Mellitus, Non-Insulin-Dependent;Diabetes Mellitus, Non-Insulin-Dependent;Diabetes Mellitus, Non-Insulin-Dependent
- Argentina, Australia, Austria, Belarus, Bermuda, Brazil, Canada, Chile, China, Colombia, Croatia, Denmark, Estonia, Finland, France, Germany, Hungary, India, Ireland, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Philippines, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States, Venezuela
- 2003-10-01
